The Beginning of the End for Expensive Aggressive Nonbeneficial End-of-Life Treatments
Posted Feb 21 2009 10:14pm
The recently-signedAmerican Recovery and Reinvestment Act of 2009provides $700,000,000 for comparative effectiveness research (page 63). The new law also establishes a Federal Coordinating Council for Comparative Effectiveness Research. "The Council shall foster optimum coordination of comparative effectiveness and related health services research . . . ." The goal is to save money.
By knowing what works best and presenting this information more broadly to patients and healthcare professionals, those items, procedures, and interventions that are most effective to prevent, control, and treat health conditions will be utilized, whilethose that are found to be less effective and in some cases, more expensive, will no longer be prescribed. Substantially increasing the Federal investment in comparative effectiveness research has the potential to yield significant payoffs in reducing health care expenditures and improving quality.